Journal ArticleOPEN ACCESS

The evolutionary safety of mutagenic drugs should be assessed before drug approval

PLoS Biology (2024) 22(3 March)
DOI: 10.1371/journal.pbio.3002570
1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Lobinska, G., Tretyachenko, V., Dahan, O., Nowak, M. A., & Pilpel, Y. (2024). The evolutionary safety of mutagenic drugs should be assessed before drug approval. PLoS Biology, 22(3 March). https://doi.org/10.1371/journal.pbio.3002570

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free